The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.The seventh seminar in the series, T cell Selection for Adoptive Cell Therapy: A Deep Dive in Cancer Immunotherapy Targets, was held January 25, 2022 from 11:30 a.m. - 1:30 p.m. ET.Moderators:
Presenters:
Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, and Merck & Co., Inc. (as of 5/18/2021).
01:56:54
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us